nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Hepatic pain—Topotecan—cervical cancer	0.0858	0.205	CcSEcCtD
Capecitabine—DPYD—uterine cervix—cervical cancer	0.0264	0.0608	CbGeAlD
Capecitabine—CDA—uterine cervix—cervical cancer	0.0254	0.0585	CbGeAlD
Capecitabine—DPYD—decidua—cervical cancer	0.0251	0.058	CbGeAlD
Capecitabine—CDA—decidua—cervical cancer	0.0242	0.0558	CbGeAlD
Capecitabine—CDA—endometrium—cervical cancer	0.0229	0.0529	CbGeAlD
Capecitabine—CDA—mammalian vulva—cervical cancer	0.0222	0.0512	CbGeAlD
Capecitabine—DPYD—uterus—cervical cancer	0.022	0.0507	CbGeAlD
Capecitabine—DPYD—female gonad—cervical cancer	0.018	0.0415	CbGeAlD
Capecitabine—CDA—vagina—cervical cancer	0.0172	0.0397	CbGeAlD
Capecitabine—TYMP—uterine cervix—cervical cancer	0.0153	0.0353	CbGeAlD
Capecitabine—TYMP—decidua—cervical cancer	0.0145	0.0336	CbGeAlD
Capecitabine—DPYD—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0141	0.0953	CbGpPWpGaD
Capecitabine—TYMP—endometrium—cervical cancer	0.0138	0.0319	CbGeAlD
Capecitabine—TYMP—mammalian vulva—cervical cancer	0.0134	0.0308	CbGeAlD
Capecitabine—TYMS—uterine cervix—cervical cancer	0.0131	0.0302	CbGeAlD
Capecitabine—Mucosal inflammation—Topotecan—cervical cancer	0.0129	0.0308	CcSEcCtD
Capecitabine—TYMP—uterus—cervical cancer	0.0127	0.0294	CbGeAlD
Capecitabine—CDA—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0126	0.085	CbGpPWpGaD
Capecitabine—Febrile neutropenia—Topotecan—cervical cancer	0.0119	0.0284	CcSEcCtD
Capecitabine—TYMS—endometrium—cervical cancer	0.0118	0.0274	CbGeAlD
Capecitabine—DPYD—lymph node—cervical cancer	0.0115	0.0267	CbGeAlD
Capecitabine—TYMS—mammalian vulva—cervical cancer	0.0115	0.0265	CbGeAlD
Capecitabine—TYMP—female reproductive system—cervical cancer	0.0114	0.0264	CbGeAlD
Capecitabine—CDA—lymph node—cervical cancer	0.0111	0.0257	CbGeAlD
Capecitabine—Intestinal obstruction—Topotecan—cervical cancer	0.0105	0.025	CcSEcCtD
Capecitabine—TYMP—female gonad—cervical cancer	0.0104	0.024	CbGeAlD
Capecitabine—TYMP—vagina—cervical cancer	0.0103	0.0239	CbGeAlD
Capecitabine—Neuralgia—Topotecan—cervical cancer	0.0103	0.0246	CcSEcCtD
Capecitabine—TYMP—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0101	0.0679	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00989	0.0667	CbGpPWpGaD
Capecitabine—CES1—female reproductive system—cervical cancer	0.00988	0.0228	CbGeAlD
Capecitabine—TYMS—female reproductive system—cervical cancer	0.00981	0.0227	CbGeAlD
Capecitabine—Pleural effusion—Topotecan—cervical cancer	0.00933	0.0223	CcSEcCtD
Capecitabine—Rash erythematous—Topotecan—cervical cancer	0.00933	0.0223	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—YY1—cervical cancer	0.0092	0.062	CbGpPWpGaD
Capecitabine—CES1—female gonad—cervical cancer	0.00899	0.0207	CbGeAlD
Capecitabine—TYMS—female gonad—cervical cancer	0.00893	0.0206	CbGeAlD
Capecitabine—TYMS—vagina—cervical cancer	0.00888	0.0205	CbGeAlD
Capecitabine—CDA—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00881	0.0594	CbGpPWpGaD
Capecitabine—Rigors—Topotecan—cervical cancer	0.00875	0.0209	CcSEcCtD
Capecitabine—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00786	0.0188	CcSEcCtD
Capecitabine—Blood bilirubin increased—Topotecan—cervical cancer	0.00755	0.018	CcSEcCtD
Capecitabine—Bone pain—Topotecan—cervical cancer	0.00746	0.0178	CcSEcCtD
Capecitabine—CES1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00743	0.0501	CbGpPWpGaD
Capecitabine—Pulmonary embolism—Topotecan—cervical cancer	0.00715	0.0171	CcSEcCtD
Capecitabine—TYMP—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00705	0.0475	CbGpPWpGaD
Capecitabine—Colitis—Topotecan—cervical cancer	0.00686	0.0164	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—FGFR3—cervical cancer	0.00678	0.0457	CbGpPWpGaD
Capecitabine—Neuropathy—Topotecan—cervical cancer	0.00671	0.016	CcSEcCtD
Capecitabine—TYMP—lymph node—cervical cancer	0.00669	0.0155	CbGeAlD
Capecitabine—Neoplasm—Topotecan—cervical cancer	0.00646	0.0154	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—YY1—cervical cancer	0.00638	0.043	CbGpPWpGaD
Capecitabine—Sepsis—Topotecan—cervical cancer	0.0062	0.0148	CcSEcCtD
Capecitabine—Ear pain—Topotecan—cervical cancer	0.00608	0.0145	CcSEcCtD
Capecitabine—CES1—lymph node—cervical cancer	0.00578	0.0133	CbGeAlD
Capecitabine—TYMS—lymph node—cervical cancer	0.00574	0.0133	CbGeAlD
Capecitabine—Dermatitis bullous—Topotecan—cervical cancer	0.00543	0.013	CcSEcCtD
Capecitabine—Lethargy—Topotecan—cervical cancer	0.00529	0.0126	CcSEcCtD
Capecitabine—CES1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0052	0.035	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00515	0.0348	CbGpPWpGaD
Capecitabine—Cardiac arrest—Topotecan—cervical cancer	0.00493	0.0118	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00467	0.0112	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00457	0.0109	CcSEcCtD
Capecitabine—CYP2C9—female reproductive system—cervical cancer	0.00429	0.00989	CbGeAlD
Capecitabine—Pancytopenia—Topotecan—cervical cancer	0.00426	0.0102	CcSEcCtD
Capecitabine—Neutropenia—Topotecan—cervical cancer	0.00419	0.01	CcSEcCtD
Capecitabine—TYMS—One Carbon Metabolism—MTHFR—cervical cancer	0.00411	0.0277	CbGpPWpGaD
Capecitabine—Weight increased—Topotecan—cervical cancer	0.00408	0.00975	CcSEcCtD
Capecitabine—Pneumonia—Topotecan—cervical cancer	0.00402	0.00961	CcSEcCtD
Capecitabine—Infestation NOS—Topotecan—cervical cancer	0.004	0.00955	CcSEcCtD
Capecitabine—Infestation—Topotecan—cervical cancer	0.004	0.00955	CcSEcCtD
Capecitabine—Neuropathy peripheral—Topotecan—cervical cancer	0.00392	0.00936	CcSEcCtD
Capecitabine—Stomatitis—Topotecan—cervical cancer	0.0039	0.00931	CcSEcCtD
Capecitabine—Hepatobiliary disease—Topotecan—cervical cancer	0.00378	0.00903	CcSEcCtD
Capecitabine—Epistaxis—Topotecan—cervical cancer	0.00377	0.00901	CcSEcCtD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—cervical cancer	0.00375	0.0253	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.00369	0.0249	CbGpPWpGaD
Capecitabine—Haemoglobin—Topotecan—cervical cancer	0.00361	0.00862	CcSEcCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0036	0.0243	CbGpPWpGaD
Capecitabine—Rhinitis—Topotecan—cervical cancer	0.0036	0.00859	CcSEcCtD
Capecitabine—Haemorrhage—Topotecan—cervical cancer	0.00359	0.00857	CcSEcCtD
Capecitabine—Hypoaesthesia—Topotecan—cervical cancer	0.00357	0.00853	CcSEcCtD
Capecitabine—Pharyngitis—Topotecan—cervical cancer	0.00356	0.00851	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—EGFR—cervical cancer	0.00335	0.0226	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—cervical cancer	0.00335	0.0226	CbGpPWpGaD
Capecitabine—Angiopathy—Topotecan—cervical cancer	0.00326	0.00778	CcSEcCtD
Capecitabine—Immune system disorder—Topotecan—cervical cancer	0.00324	0.00774	CcSEcCtD
Capecitabine—Mediastinal disorder—Topotecan—cervical cancer	0.00323	0.00773	CcSEcCtD
Capecitabine—Chills—Topotecan—cervical cancer	0.00322	0.00769	CcSEcCtD
Capecitabine—Alopecia—Topotecan—cervical cancer	0.00317	0.00758	CcSEcCtD
Capecitabine—Malnutrition—Topotecan—cervical cancer	0.00312	0.00746	CcSEcCtD
Capecitabine—Back pain—Topotecan—cervical cancer	0.00302	0.00722	CcSEcCtD
Capecitabine—Muscle spasms—Topotecan—cervical cancer	0.003	0.00718	CcSEcCtD
Capecitabine—Ill-defined disorder—Topotecan—cervical cancer	0.0029	0.00692	CcSEcCtD
Capecitabine—Anaemia—Topotecan—cervical cancer	0.00289	0.0069	CcSEcCtD
Capecitabine—Malaise—Topotecan—cervical cancer	0.00282	0.00673	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—TP53—cervical cancer	0.00281	0.019	CbGpPWpGaD
Capecitabine—Leukopenia—Topotecan—cervical cancer	0.0028	0.00668	CcSEcCtD
Capecitabine—Cough—Topotecan—cervical cancer	0.00273	0.00651	CcSEcCtD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—cervical cancer	0.00268	0.018	CbGpPWpGaD
Capecitabine—Chest pain—Topotecan—cervical cancer	0.00266	0.00635	CcSEcCtD
Capecitabine—Myalgia—Topotecan—cervical cancer	0.00266	0.00635	CcSEcCtD
Capecitabine—Arthralgia—Topotecan—cervical cancer	0.00266	0.00635	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00264	0.00631	CcSEcCtD
Capecitabine—Discomfort—Topotecan—cervical cancer	0.00263	0.00628	CcSEcCtD
Capecitabine—Infection—Topotecan—cervical cancer	0.00253	0.00605	CcSEcCtD
Capecitabine—Nervous system disorder—Topotecan—cervical cancer	0.0025	0.00597	CcSEcCtD
Capecitabine—Thrombocytopenia—Topotecan—cervical cancer	0.0025	0.00596	CcSEcCtD
Capecitabine—Skin disorder—Topotecan—cervical cancer	0.00248	0.00592	CcSEcCtD
Capecitabine—Hyperhidrosis—Topotecan—cervical cancer	0.00246	0.00589	CcSEcCtD
Capecitabine—Anorexia—Topotecan—cervical cancer	0.00243	0.00581	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00232	0.00555	CcSEcCtD
Capecitabine—Paraesthesia—Topotecan—cervical cancer	0.00229	0.00547	CcSEcCtD
Capecitabine—Dyspnoea—Topotecan—cervical cancer	0.00227	0.00543	CcSEcCtD
Capecitabine—Dyspepsia—Topotecan—cervical cancer	0.00224	0.00536	CcSEcCtD
Capecitabine—Decreased appetite—Topotecan—cervical cancer	0.00222	0.00529	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Topotecan—cervical cancer	0.0022	0.00526	CcSEcCtD
Capecitabine—Fatigue—Topotecan—cervical cancer	0.0022	0.00525	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—UBE3A—cervical cancer	0.00218	0.0147	CbGpPWpGaD
Capecitabine—Constipation—Topotecan—cervical cancer	0.00218	0.00521	CcSEcCtD
Capecitabine—Pain—Topotecan—cervical cancer	0.00218	0.00521	CcSEcCtD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00213	0.0143	CbGpPWpGaD
Capecitabine—Feeling abnormal—Topotecan—cervical cancer	0.0021	0.00502	CcSEcCtD
Capecitabine—Gastrointestinal pain—Topotecan—cervical cancer	0.00208	0.00498	CcSEcCtD
Capecitabine—Urticaria—Topotecan—cervical cancer	0.00203	0.00484	CcSEcCtD
Capecitabine—Abdominal pain—Topotecan—cervical cancer	0.00202	0.00481	CcSEcCtD
Capecitabine—Body temperature increased—Topotecan—cervical cancer	0.00202	0.00481	CcSEcCtD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—cervical cancer	0.00197	0.0133	CbGpPWpGaD
Capecitabine—Hypersensitivity—Topotecan—cervical cancer	0.00188	0.00449	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00185	0.0125	CbGpPWpGaD
Capecitabine—Asthenia—Topotecan—cervical cancer	0.00183	0.00437	CcSEcCtD
Capecitabine—Pruritus—Topotecan—cervical cancer	0.0018	0.00431	CcSEcCtD
Capecitabine—Diarrhoea—Topotecan—cervical cancer	0.00174	0.00417	CcSEcCtD
Capecitabine—Dizziness—Topotecan—cervical cancer	0.00169	0.00403	CcSEcCtD
Capecitabine—Vomiting—Topotecan—cervical cancer	0.00162	0.00387	CcSEcCtD
Capecitabine—Rash—Topotecan—cervical cancer	0.00161	0.00384	CcSEcCtD
Capecitabine—Dermatitis—Topotecan—cervical cancer	0.00161	0.00384	CcSEcCtD
Capecitabine—Headache—Topotecan—cervical cancer	0.0016	0.00382	CcSEcCtD
Capecitabine—Nausea—Topotecan—cervical cancer	0.00151	0.00362	CcSEcCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—cervical cancer	0.00137	0.00923	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CA9—cervical cancer	0.00111	0.0075	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA9—cervical cancer	0.000992	0.00669	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA9—cervical cancer	0.000793	0.00534	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000692	0.00467	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.00063	0.00425	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000524	0.00353	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000505	0.00341	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MTHFR—cervical cancer	0.000451	0.00304	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CA9—cervical cancer	0.000406	0.00273	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTHFR—cervical cancer	0.000402	0.00271	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.0004	0.0027	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—cervical cancer	0.000382	0.00258	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000336	0.00227	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—cervical cancer	0.000323	0.00217	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—cervical cancer	0.000322	0.00217	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—cervical cancer	0.000165	0.00111	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—cervical cancer	0.000145	0.00098	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CA9—cervical cancer	0.000117	0.000788	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—cervical cancer	4.74e-05	0.00032	CbGpPWpGaD
